Mayo Clinic researchers have developed an innovative testing strategy for mesothelioma that could potentially increase the ...

The CHMP renders a positive opinion recommending approval for MRK's Keytruda for the first-line treatment of malignant ...

Mesothelioma is a rare cancer caused by asbestos exposure, with military personnel being among the groups at highest risk due ...

Mesothelioma is connected to asbestos exposure, and its symptoms typically don’t appear until decades after exposure.

Mayo Clinic researchers have developed an innovative testing strategy for mesothelioma that could potentially increase the detection rate of cancer DNA in the blood.

Merck & Co. Inc.’s stock rose 2% premarket Tuesday, after the company reported positive results for a new, ...

"Mayo Clinic develops mesothelioma detection method" was originally created and published by Medical Device Network, a ...

Capsaicin, the compound in chili peppers which gives them their spicy taste, may become a source of new, natural drugs for ...

The U.S. Food and Drug Administration approved the Keytruda combination in malignant pleural mesothelioma in September. Keytruda, a cancer drug that harnesses a patient's immune system to fight tumors ...

Mayo Clinic says this testing approach could help detect mesothelioma, a rare cancer that develops in the thin membranes that ...